Archives

img-01

Myopia Remains High in Asia

Myopia, also known as near-sightedness, is continuing to grow at an alarming rate throughout the youth population in Asia. Singapore, South Korea, Japan and Taiwan have traditionally been myopia hotspots, with over 80% of young adults affected by the condition. In recent... Read More

img-01

Orphan Drugs in Asia Report 2017

Following the example of the U.S. FDA's Orphan Drug Act established in 1983, some Asian countries have developed orphan drug legislation, such as Singapore's Orphan Drug Exemption to the Medicines Act and Japan's Orphan Drug Amendment to the Pharmaceutical Affairs Law. While... Read More

img-01

Embryonic Stem Cells in Japan

Embryonic stem cells will be available in Japan for regenerative medicine uses by March 2018. The embryonic stem cells will be derived from fertilized eggs obtained at an infertility hospital that would otherwise be disposed of. This may be a favorable option... Read More

img-01

Japan Orphan Drug Update 2017

Introduction Japan has some of the highest healthcare standards in the world, with the Japanese government providing health insurance for approximately 99% of its citizens. After the United States, Japan was the second country to establish regulations for the development of orphan... Read More

img-01

Japan Looking to Target Rehabilitation Robotics Market

The global market for rehabilitation robotics is anticipated to increase rapidly, and Japanese manufacturers are following suit by targeting this market. The demand for rehabilitation robots will especially be high in Japan due to its rapidly aging and shrinking population. Rehabilitation robots... Read More